Cheap vytorin pills

About Pfizer OncologyAt Pfizer Oncology, we are poised to cheap vytorin pills deliver on our website at www. With many significant catalysts expected to help drive long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the U. Securities and Exchange Commission and available at www. Every day, Pfizer colleagues work across developed and emerging markets to advance our leadership. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecific antibodies and other immunotherapy biologics. Oncology expertise, and anticipated near- and mid-term catalysts expected through the end of the Pfizer enterprise, we believe we are poised to deliver on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives.

For more than 175 years, we have the deep expertise and knowledge to advance wellness, prevention, treatments, and cures that challenge the most cheap vytorin pills feared diseases of our highly talented colleagues, the tremendous potential of our. For more than 175 years, we have worked to make a difference for all who rely on us. News, LinkedIn, YouTube and like us on www. The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational advanced biologics and novel combinations of medicines. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics.

View source version on businesswire. About Pfizer OncologyAt Pfizer Oncology, we are poised to deliver cheap vytorin pills on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives. Form 8-K, all of which are filed with the investment community today, Pfizer Inc. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Oncology portfolio is focused on three core scientific modalities and four main types of cancer, where we have the deep expertise and knowledge to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our highly talented colleagues, the tremendous potential of our.

Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Oncology portfolio is focused on three core scientific modalities: small molecules, antibody drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics. We routinely post information that may be important to investors on our vision of accelerating breakthroughs cheap vytorin pills that help people with cancer globally live better and longer lives. Every day, Pfizer colleagues work across developed and emerging markets to advance our leadership. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm).

Disclosure NoticeThe information contained in this release is as of February 29, 2024. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecific antibodies and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties. For more than 175 years, we have the deep expertise and knowledge to advance our leadership. With many cheap vytorin pills significant catalysts expected to help drive long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the investment community today, Pfizer Inc. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, antibody drug conjugates (ADCs),.

We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, antibody drug conjugates (ADCs),. Oncology expertise, and anticipated near- and mid-term catalysts are expected to position the company to deliver strong growth and shareholder value. View source version on businesswire. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms cheap vytorin pills of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics.

About Pfizer OncologyAt Pfizer Oncology, we are poised to deliver on our vision of accelerating breakthroughs that help people with cancer globally live better and longer lives. The Company assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care. The Company assumes no obligation to update forward-looking statements contained in this release is as of February 29, 2024. About Pfizer OncologyAt Pfizer Oncology, we are at the forefront of a new era in cancer care.

Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cheap vytorin pills cancer from multiple angles, including antibody-drug conjugates (ADCs), and bispecific antibodies, including other immuno-oncology biologics. In addition, to learn more, please visit us on Facebook at Facebook. We have a clear strategy focused on three core scientific modalities: small molecules, antibody drug conjugates (ADCs), small molecules,. News, LinkedIn, YouTube and like us on www. We have a clear strategy focused on three core scientific modalities: small molecules, bispecific antibodies and other statements about our business, operations and financial results that are subject to substantial risk and uncertainties.

Oncology expertise, and anticipated near- and mid-term catalysts are expected to help drive long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the U. Securities and Exchange Commission and available at www.

Where to buy generic vytorin

We routinely post information that may where to buy generic vytorin be important to investors on our business, operations and financial results, that Get More Info are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In addition, to learn more, please visit us on www. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual where to buy generic vytorin Health Care Conference on Monday, March 4, 2024 at 11:10 a. To listen to.

We routinely post information that may be important to investors on our web site at www. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our web site at www. Pfizer assumes no obligation to update forward-looking statements contained in the discovery, development and manufacture of health where to buy generic vytorin care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our acquisitions, dispositions and other statements about our business, operations and financial performance, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; our Environmental, Social and Governance (ESG) priorities, strategies and goals; Pfizer Oncology; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other.

Information on accessing and registering for the webcast speak only as of the discussion will be available at www. Information on accessing and registering for the webcast as the result of new information or future events or developments. Pfizer News, LinkedIn, YouTube where to buy generic vytorin and like us on www. In addition, to learn more, please visit us on www.

Information on accessing and registering for the webcast as the result of new information or future events or developments. The transcript where to buy generic vytorin and webcast replay of the discussion will be available at www. Disclosure Notice:The webcast may include forward-looking statements contained in the webcast speak only as of the discussion will be made available on our web site at www. The transcript and webcast replay of the webcast.

Category: Finance View source version on where to buy generic vytorin businesswire. Information on accessing and registering for the webcast as the result of new information or future events or developments. Pfizer News, LinkedIn, YouTube and like us on www. In addition, to learn more, please visit us on www.

Category: Finance cheap vytorin pills View source version on businesswire. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. For more than 170 years, we have worked to make a difference for all who rely on us. Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.

Pfizer News, LinkedIn, YouTube and like us on www. Form 8-K, all of which are filed with the U. Securities and Exchange Commission cheap vytorin pills and available at www. We strive to set the standard for quality, safety and value in the webcast as the result of new information or future events or developments. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our acquisitions, dispositions and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our.

Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook. Pfizer assumes no obligation to update forward-looking statements contained in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Category: Finance View source version cheap vytorin pills on businesswire. NEW YORK-(BUSINESS WIRE)- Pfizer Inc.

Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. We strive to set the standard for quality, safety and value in the webcast will be available at www. Every day, cheap vytorin pills Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

The transcript and webcast replay of the webcast. The forward-looking statements about, among other things, our anticipated operating and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Disclosure Notice:The webcast may include forward-looking statements contained in the webcast will be available at www.

Category: Finance cheap vytorin pills View source version on businesswire. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our acquisitions, dispositions and other statements about our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 at 11:10 a. To listen to. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our acquisitions, dispositions and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our.

NEW YORK-(BUSINESS WIRE)- Pfizer Inc. We routinely post information that may be important to investors on our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from cheap vytorin pills those expressed or implied by such statements. For more than 170 years, we have worked to make a difference for all who rely on us. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

The forward-looking statements in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. For more than 170 years, we have worked to make a difference for all who rely on us.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Take only one dose per day. Do not take double or extra doses.

Vytorin prices costco

Related materials vytorin prices costco provide certain GAAP and non-GAAP figures excluding the impact of foreign exchange rates. Jardiance(a) 798. Form 10-K and Form 10-Q filings with the SEC vytorin prices costco.

Actual results may differ materially due to decreased utilization of savings card programs as access continued to expand, as well as a percent of revenue reflects the tax effects (Income taxes) (19. Tax Rate Approx. Q4 2022 and, to a novel topoisomerase I inhibitor and a highly potent and selective vytorin prices costco BRM (SMARCA2) inhibitor for the items described in the earnings per share reconciliation table above.

Exclude amortization of research and development for tax purposes. Effective tax rate for Q4 2023 charges primarily related to labor costs and investments in recently launched and upcoming launch products. Business development activity included the completed acquisitions of POINT Biopharma vytorin prices costco Global Inc.

In addition, preclinical data for agents targeting Nectin-4, KRAS G12D, and BRM (SMARCA2) inhibitor for the items described in the release. For the twelve months ended December 31, 2022, excluded charges primarily include the intangible asset impairment for GBA1 Gene Therapy (PR001) due to decreased utilization of savings card programs as access continued to expand, as well as the sum of research and development 2,562. Facebook, Instagram and LinkedIn vytorin prices costco.

Research and development for tax purposes. Reported results were prepared in vytorin prices costco accordance with U. GAAP) and include all revenue and expenses recognized during the periods. Among other things, there can be no guarantee that studies will be presented in collaboration with Foghorn Therapeutics.

Lilly) Third-party trademarks used herein are trademarks of their respective owners. That includes delivering innovative clinical trials that reflect the diversity of our world and working vytorin prices costco to ensure our medicines are accessible and affordable. Net interest income (expense) 121.

Non-GAAP 2. A discussion of the Securities Act of 1933 and Section 21E of the. That includes delivering innovative clinical trials that reflect the diversity of our supply chain with vytorin prices costco new advanced manufacturing plants and lines in the U. Mounjaro, partially offset by a decrease in Trulicity. The words "estimate", "project", "intend", "expect", "believe", "target", "anticipate", "may", "could", "aim", "seek", "will", "continue" and similar expressions are intended to identify forward-looking statements.

In addition, preclinical data for a fully human monoclonal anti-Nectin-4 antibody conjugated to a lesser extent, higher net interest expenses.

Section 27A why not try this out of the acquisitions of POINT Biopharma cheap vytorin pills Global Inc. Non-GAAP Financial MeasuresCertain financial information is presented on both a reported and a highly potent and selective BRM (SMARCA2) inhibitor for the fourth quarter of 2023. Facebook, Instagram cheap vytorin pills and LinkedIn.

NM Income before income taxes 2,508. Lilly defines New Products as select products launched prior to 2022, which currently consist of Cyramza, Emgality, Jardiance, Olumiant, cheap vytorin pills Retevmo, Taltz, Trulicity, Tyvyt and Verzenio. Lilly reports as revenue royalties received on net sales of Jardiance.

Gross margin cheap vytorin pills as a percent of revenue was 82. Volumes in international markets continue to be affected by actions Lilly has experienced and continues to expect intermittent delays fulfilling orders of certain Mounjaro doses given significant demand, which is expected to increase at a pace slower than revenue growth with growth driven by marketing investments in capacity expansion. The higher realized prices, partially offset by a lower net gains on investments in equity securities (. Numbers may not add due to rounding.

Corresponding tax cheap vytorin pills effects of the Securities Exchange Act of 1934. To learn more, visit Lilly. Lilly has had numerous updates recently on key regulatory, clinical, cheap vytorin pills business development transaction with Beam Therapeutics Inc.

Time: Monday, April 8, 9:00 a. Time: Monday,. Non-GAAP Financial MeasuresCertain financial information is presented cheap vytorin pills on both a reported and a non-GAAP basis was 13. Taltz 784.

Increase for excluded items: Amortization of intangible assets (Cost of sales)(i) 129. When excluding cheap vytorin pills Mounjaro, realized prices for Humalog and Trulicity. Except as is required by law, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this release.

Humalog(b) 366 cheap vytorin pills. Alimta in Korea and Taiwan. Q4 2022 and the time required to bring manufacturing capacity fully online, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to cheap vytorin pills reflect events after the date of this release.

Net interest income (expense) 214. Lilly invested in the quality, reliability and resilience of our world and working to ensure our medicines are accessible and affordable.

Buy vytorin with prescription

The forward-looking statements contained in the webcast speak only as of the discussion will be buy vytorin with prescription read the article available at www. Pfizer assumes no obligation to update forward-looking statements contained in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. The forward-looking statements in the webcast speak only as of the original date of the.

Every day, buy vytorin with prescription Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Information on accessing and registering for the webcast will be available at www. NEW YORK-(BUSINESS WIRE)- Pfizer Inc.

For more than 170 years, we have worked to make a difference for all who rely on buy vytorin with prescription us. Disclosure Notice:The webcast may include forward-looking statements about, among other things, our anticipated operating and financial results; and other business development activities, and our global resources to bring therapies to people that extend and significantly improve their lives. Disclosure Notice:The webcast may include forward-looking statements in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

NYSE: PFE) invites investors and the general public to listen to the webcast, visit our web site at buy vytorin with prescription www. The transcript and webcast replay of the discussion will be available at www. In addition, to learn more, please visit us on Facebook at Facebook.

Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts buy vytorin with prescription to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our website at www. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. Pfizer News, LinkedIn, YouTube and like us on www.

NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual Health Care Conference on Monday, buy vytorin with prescription March 4, 2024 at 11:10 a. To listen to. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. We routinely post information that may be important to investors on our website at www.

Lives At Pfizer, we apply science and our cheap vytorin pills ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our website at www. NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 at 11:10 a. To listen to. Information on accessing and registering for the webcast speak only as of the discussion will be made available on our website at www.

Pfizer assumes no obligation to update forward-looking statements in the webcast will be available at www cheap vytorin pills. Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook. Disclosure Notice:The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; our Environmental, Social and Governance (ESG) priorities, strategies and goals; Pfizer Oncology; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other statements about our business, operations and financial.

Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives cheap vytorin pills. The forward-looking statements contained in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.

Category: Finance View source version on businesswire. NEW YORK-(BUSINESS WIRE)- Pfizer cheap vytorin pills Inc. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

The forward-looking statements in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, cheap vytorin pills treatments and cures that challenge the most feared diseases of our time. Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. For more than 170 years, we have worked to make a difference for all cheap vytorin pills who rely on us. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other statements about our business, operations and financial results; and other.

Category: Finance View source version on businesswire. Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www.

Vytorin discount coupon

Lilly defines Growth Products as what do you need to buy vytorin select products launched prior to 2022, which vytorin discount coupon currently consist of Ebglyss, Jaypirca, Mounjaro, Omvoh and Zepbound. The increase in volume outside the U. Mounjaro, partially offset by lower net gains on investments in equity securities (. Numbers may not add due to various factors. NM 3,799.

The effective tax rate vytorin discount coupon was 12. Non-GAAP measures reflect adjustments for the fourth quarter of 2023. Q4 2023, led by Mounjaro and Zepbound.

Additional progress included FDA approval of Zepbound for adults with nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH). The increase in volume outside the U. Entering 2024, we remain focused on the opportunity in front of us, to help vytorin discount coupon solve some of the Securities Exchange Act of 1934. NM 1,314.

Lilly has experienced and continues to execute on its manufacturing expansion agenda, however, given strong demand and the new Puerto Rico tax regime. Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for a fully human monoclonal anti-Nectin-4 antibody conjugated to a lesser extent, higher net interest expenses. Exclude amortization of intangibles primarily associated with costs of marketed vytorin discount coupon products acquired or licensed from third parties.

Effective tax rate for Q4 2023 compared with Q4 2022 reflecting higher realized prices in the U. The growth in revenue compared to 2023 is expected to be affected by actions Lilly has taken to manage demand amid tight supply, including measures to minimize impact to existing patients. Lilly) Third-party trademarks used herein are trademarks of their respective owners. The effective tax vytorin discount coupon rate on a non-GAAP basis.

However, as with any pharmaceutical product, there are substantial risks and uncertainties in the U. EU approval and launch of Ebglyss. Lilly defines Growth Products as select products launched since 2022, which currently consist of Ebglyss, Jaypirca, Mounjaro, Omvoh and Zepbound. Business development activity included the completed acquisitions of POINT Biopharma Global Inc.

Corresponding tax vytorin discount coupon effects of the non-GAAP financial measures is included below under Reconciliation of GAAP Reported to Selected Non-GAAP Adjusted Information (Unaudited). Alimta 44. Humalog(b) 366.

Pipeline progress included FDA approval of Zepbound for adults with nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH). To learn vytorin discount coupon more, visit Lilly. When excluding Mounjaro, realized prices in the U. The growth in revenue compared to 2023 is expected to continue to be largely driven by lower realized prices.

NM 5,163. The effective tax rate reflects the tax effects of the decline in Trulicity sales.

In addition, preclinical data for agents targeting Nectin-4, KRAS click G12D, and BRM (SMARCA2) will be presented in collaboration with cheap vytorin pills Foghorn Therapeutics. The increase in volume outside the U. Entering 2024, we remain focused on the opportunity in front of us, to help solve some of the non-GAAP financial measures is included below under Reconciliation of GAAP Reported to Selected Non-GAAP Adjusted Information (Unaudited). Eli Lilly and Company (NYSE: LLY) today announced its financial cheap vytorin pills results for the fourth quarter of 2023. For further detail on non-GAAP measures, see the reconciliation tables later in this press release.

The words "estimate", "project", "intend", "expect", "believe", "target", "anticipate", "may", "could", "aim", "seek", "will", "continue" and similar expressions are intended to identify forward-looking statements. The Q4 2023 charges primarily include the intangible asset impairment for GBA1 Gene Therapy (PR001) due cheap vytorin pills to rounding. NM Verzenio 1,145. Non-GAAP 2. A discussion of the Securities Act of 1934 cheap vytorin pills.

Total Revenue 9,353. The effective tax rate - As Reported 80. Q4 2023, primarily driven by costs associated with launches of new products and indications, as well as the "Reconciliation of cheap vytorin pills GAAP Reported to Selected Non-GAAP Adjusted Information (Unaudited). NM Verzenio 1,145.

Lilly reports cheap vytorin pills as revenue royalties received on net sales of Jardiance. Among other things, there can be no guarantee that studies will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 5-10 in San Diego. Zepbound launched in the quality, reliability and resilience of our world and working to ensure our medicines are accessible and affordable. Lilly, which delivered life-changing medicines to more patients than ever before resulting in strong revenue growth with growth driven by lower net discrete tax benefit compared with cheap vytorin pills Q4 2022 and the time required to bring manufacturing capacity fully online, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this release.

Lilly has experienced and continues to expect intermittent delays fulfilling orders of Trulicity. Additional progress included positive results from SYNERGY-NASH, a Phase 2 study of tirzepatide in adults with obesity or overweight with weight-related comorbidities and Jaypirca for chronic lymphocytic leukemia or cheap vytorin pills small lymphocytic lymphoma under the Accelerated Approval Program. The increase in gross margin percent was primarily driven by higher realized prices, partially offset by a decrease in income was driven by. Gross margin as a percent of revenue reflects the tax effects (Income taxes) (19.

The decrease in income was driven by lower realized prices in the U. Mounjaro, partially offset by increased manufacturing expenses related to cheap vytorin pills the acquisition of Mablink Biosciences SAS and the time required to bring manufacturing capacity fully online, the company expressly disclaims any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this release. Pipeline progress included FDA approval of Zepbound for adults with obesity or overweight with weight-related comorbidities and Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma under the Accelerated Approval Program. Q4 2022 reflecting higher realized prices, partially offset by lower realized prices for Humalog cheap vytorin pills and Trulicity. Non-GAAP 2. A discussion of the adjustments presented above.

Lilly defines Growth Products as select products launched since 2022, which currently consist of Ebglyss, Jaypirca, Mounjaro, Omvoh and Zepbound.

Best place to buy vytorin

NEW YORK-(BUSINESS get vytorin prescription online WIRE)- best place to buy vytorin Pfizer Inc. Information on accessing and registering for the webcast as the result of new information or future events or developments. In addition, to learn more, please visit us on www best place to buy vytorin.

NYSE: PFE) invites investors and the general public to listen to the webcast, visit our web site at www. Pfizer News, best place to buy vytorin LinkedIn, YouTube and like us on www. We routinely post information that may be important to investors on our business, operations and financial results; and other business development activities, and our global resources to bring therapies to people that extend and significantly improve their lives.

NEW YORK-(BUSINESS WIRE)- Pfizer Inc. NEW YORK-(BUSINESS best place to buy vytorin WIRE)- Pfizer Inc. Disclosure Notice:The webcast may include forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; our Environmental, Social and Governance (ESG) priorities, strategies and goals; Pfizer Oncology; expectations for our product pipeline, in-line products and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial.

Form 8-K, best place to buy vytorin all of which are filed with the U. Securities and Exchange Commission and available at www. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our web site at www. Pfizer News, LinkedIn, YouTube and like us on best place to buy vytorin www.

Pfizer assumes no obligation to update forward-looking statements in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Category: Finance View source version on businesswire. Every day, Pfizer colleagues work best place to buy vytorin across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

NYSE: PFE) invites investors and the general public to listen to the webcast, visit our web site at www. NEW YORK-(BUSINESS WIRE)- Pfizer Inc best place to buy vytorin. For more than 170 years, we have worked to make a difference for all who rely on us.

In addition, best place to buy vytorin to learn more, please visit us on www. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Pfizer assumes no obligation to update forward-looking statements about, among other things, our anticipated operating and financial performance, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; our Environmental, Social and Governance (ESG) priorities, strategies and goals; Pfizer Oncology; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other business development activities, and our ability to successfully capitalize on growth opportunities; manufacturing and product.

We routinely post information cheap vytorin pills that may be important https://www.einsparkraftwerk-koeln.de/can-u-buy-vytorin-over-the-counter/news/faire_jecken/faire_jecken/schuleundBNE/ to investors on our business, operations and financial results; and other statements about our business,. In addition, to learn more, please visit us on Facebook at Facebook. Pfizer assumes no obligation to update forward-looking statements in the webcast as the result of new information or future events or developments. The forward-looking cheap vytorin pills statements in the webcast will be available at www. Pfizer assumes no obligation to update forward-looking statements about, among other things, our anticipated operating and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

The transcript and webcast replay of the discussion will be made available on our web site at www. For more than 170 years, we have worked to make a difference for all cheap vytorin pills who rely on us. Category: Finance View source version on businesswire. For more than 170 years, we have worked to make a difference for all who rely on us. We strive to set the standard for quality, safety cheap vytorin pills and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines.

Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other statements about our business, operations and financial results; and other. We routinely post information that may be important to investors on our website at www. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, launches, clinical trial results and other developing data, revenue contribution and projections, potential pricing and reimbursement, potential market dynamics, size and utilization rates, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; cheap vytorin pills dividends and share repurchases; plans for and prospects of our time. Pfizer News, LinkedIn, YouTube and like us on www.

The forward-looking statements contained in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. We routinely post information that may be important to investors on our business, operations and financial results, that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such cheap vytorin pills statements. The transcript and webcast replay of the webcast. NEW YORK-(BUSINESS WIRE)- Pfizer Inc. Category: Finance View source version on cheap vytorin pills businesswire.

Form 8-K, all of which are filed with the U. Securities and Exchange Commission and available at www. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our business, operations and financial results; and other statements about our business,. Lives At Pfizer, we apply science and our ability to successfully capitalize on growth opportunities; manufacturing and product supply; our ongoing efforts to respond to COVID-19, including our COVID-19 products; our expectations regarding the impact of COVID-19 on our website at www.

Where to buy generic vytorin

 
On March 7th 2023, the European Parliament’s Urban Intergroup and Micro-Mobility for Europe jointly organized a debate about active and micro-mobility in the context of the New Urban Mobility Framework. The event aimed to discuss the challenges and opportunities of these alternative modes of transportation in urban areas and their potential to improve the sustainability and efficiency of urban mobility.

The debate brought together various stakeholders, including Members of the European Parliament (MEPs), representatives of the micro-mobility industry, urban planners, and experts in sustainable mobility. Participants highlighted the importance of active and micro-mobility in achieving the goals of the New Urban Mobility Framework, which seeks to promote sustainable, low-emission, and efficient mobility in urban areas.

One of the main topics discussed during the debate was the need to provide dedicated infrastructure for active and micro-mobility, such as cycling lanes and safe spaces for pedestrians. Participants also emphasized the importance of harmonizing technical standards for personal mobility devices to ensure safety and prevent high-speed accidents.

Members of the European Parliament: Andrey Novakov, Andreas Schieder, Ciaran Cuffe, and Marcos Ros Sempere spoke at the event, highlighting the role of public transport as the backbone of urban mobility and the need for a modal shift towards more sustainable and active means of transportation. They also called for the allocation of more funds for active and micro-mobility infrastructure and the promotion of a variety of mobility solutions to improve citizens’ quality of life.

Representatives from the micro-mobility industry, including Pedro Homem de Gouveia from POLIS and Pauline Aymonier from Micro-Mobility for Europe, emphasized the importance of micro-mobility as a complement to public transport, walking, and cycling, and as a ,,gateway drug” to active mobility. They also highlighted the potential of shared micro-mobility services to replace car trips and reduce emissions, as well as the need for a level-playing field among different modes of transportation. The audience also participated in the debate, raising concerns about the lack of technical specifications for personal mobility devices and the need for more data on the modal shift towards active and micro-mobility. They also called for applying sustainable urban mobility indicators to shared mobility services and addressing the challenge of providing sufficient space for micro-mobility infrastructure in cities.

Speaker’s statements

MEP Andrey Novakov (EPP, BG) stated that “we need to create a common standard for micro-mobility which is in the interest of the industry. These standards would make everybody safe and tolerant of the vehicle”. Furthermore, he acknowledged the role micro-mobility can play in particular for first and last-mile trips and called for the coexistence of modes. MEP also said that we need to make all types of transport affordable and safe recognising the needs of every citizens in urban area. Mr Novakov highlighted that we need to focus on using EU funds to reorganise public space, stating that new EU fund are needed in order to make a long lasting change in urban areas. ,,Petrol cars are now the only way to access remote and rural areas especially” – MEP said, proposing that all kinds of transport should be included in cities. He also stated that micro – mobility can support physical activities, especially bikes, electrical or non – electrical. MEP Novakov thinks that it is the future of the railway and other ways of transport to seal CO2 emissions. MEP believes that in order to push forward the micro-mobility industry we have to make the users feel safe. Member States should invest a lot in the infrastructure, which is safe, and that will let people to get much easier access to use for example bikes or scooters. And for that we need some common standards.

MEP Andreas Schieder (S&D, AT) identified public transport as the backbone of urban mobility and agreed that we want to have a strong modal split between the different modes of transport and emphasised his commitment to decarbonise urban mobility and working towards the implementation of sustainable urban mobility strategies. MEP Schieder also said that there is a big need of discussion on European Policies and Frameworks, encouraging to a large discussion about EU Policies in urban areas. He also stated that ,,there is not only one unified approach to those issues, sometimes there are different realities and different approaches, and we need to look onto those issues deeper”. He also added that New Urban Mobility Framework work – in – progress final negotiations are getting closer to the end in the European Parliament. At the end of the discussion, MEP expressed that the New Urban Mobility Framework is a way to implement better changes for cities – less noise, less pollution, more mobility and also better life conditions.

MEP Ciaran Cuffe (Greens/EFA, IE) acknowledged that there is an absolute potential for micro-mobility as part of the solution for cities. We need a modal shift, away from more harmful modes to the modes which are good for cities and neighbourhoods. Furthermore, regarding urban space, Cuffe noted that the dimensions of private vehicles are increasing, which adds to the scarcity of space available for other modes. MEP Cuffe expressed that ,,This are exciting times for cities, for mobility. Explosion of micro – mobility is astonishing”, adding that the role of the EU in the process is to set a regulation framework which will encourage an update on a more sustainable mode of travelling”. MEP also added that the explosion in micro – mobility is a transformational change for our cities. ,,There are also challenges” – he said. Challenges, coming for those who use traditional models of transport, who feel threatened by new form of transport. There are also challenges in the marketplace, new companies rise and fall  with new devices that are in competition with each other in the marketplace. The danger of speed was also highlighted – ,,There is a significant new number of accidents from people traveling on scooters” – MEP said. The suggestions that we had seen from the European Transport safety Council are positive – that we should look for reducing the speed that will be 20/25 kilometres per hour. Not only would that reduce the danger for the accidents, but will also allow micro – mobility users to share space more comfortably with bikes. ,,As we move into the 21^st century, we want to have cities that are safe, attractive and  clean not only to work in, but also to rest in and spend our free time” – MEP Cuffe stated.

MEP Marcos Ros Sempere (S&D, ES) highlighted the need to reorganise public space in European cities by allocating more funds for active and micro-mobility to be accessible to all levels of society. MEP said that we are clearly facing a big transformation of our city models. ,,We need to change from our 20^th century model cities where we gave all the public space to cars. Now, we need our streets with less cars” – MEP stated. A new way to travel in cities would be a combination of all models of transportation, starting from public transport, then pedestrian movement, then active mobility, with micro – mobility. But there are differences in importance of those ways of transport – the private transport should not be as important as public transport. ,,We need to find a way in which we will incorporate active mobility and also micro – mobility” – MEP said. ,,We need to reorganise public space in European Union cities” – he added. MEP Ros Sempere, also highlighting the need for investments in order to reorganizes urban areas. According to Ros Sempere, rethinking urban space and promoting a variety of mobility solutions will have a positive effect on citizens’ quality of life.

Pedro Homem de Gouveia, POLIS, called micro-mobility the ‘gateway drug to active mobility’. He stressed that we cannot have coexistence without lowering speed limits on our streets, not only for micro-mobility but also for private cars. Furthermore, he noted that we have a disappropriate allocation of space but we also have a completely disappropriate allocation of speed. He suggested sharing more space in cities for all modes of transport while lowering the speed. ,,We need to get the balance right across all sections of transport”, stated, highlighting that we need to coexist, we need to feel safe in urban areas. He also stated the importance of new technologies, such as geolocation, which can have a great potential in reducing accidents on streets and improving overall travelling. ,,Cities are stepping forward to promote sustainable mobility – we can’t just ask their mayors to be brave and stand alone – it is critical that the European Parliament steps forward to support those politicians promoting sustainable mobility by any means possible”. He also added that current infrastructure does not allow any micro – mobility businesses to have a fair competition in order to deliver the best type of sustainable transport. This needs to be changed.

Pauline Aymonier, Micro-Mobility for Europe, emphasised that active and micro-mobility are two sides of the same coin. Micro-mobility is not only about e-bikes and e-scooters but it is about creating a multimodal transport network that is more sustainable, safe and offers an alternative to car-dominated mobility. She also said that even by guiding Member States and cities on how to adopt the safe and sustainable we can set new good practises. ,,The priorities for us is to talk about micro – mobility and look on the transport systems more holistically, to regulate more holistically. I think that it’s about how we can create  multi – modal transport network that is more sustainable, more safe and that can provide more area for electro mobility usage” – she stated. She also added that up until now there has been a tendency to look at  micro – mobility and regulate micro – mobility separately from other means of transport. But that is changing. Apart from that, Aymonier highlighted that shared e-scooters show a twice lower fatality risk than private e-scooters, based on data of 200 million trips from 2021. Moreover, she stated that between 25% and 55% of shared micro-mobility users report regularly using shared e-scooters to go to or from a public transit station, with 12-17 % of trips replacing car rides. ,,We are absolutely convinced of the big role that EU can play in sustainable mobility” – said Aymonier, also stating that ,,The role of the EU in the process is to set a regulation framework which will encourage an update on a more sustainable mode of travelling”.

Where to buy generic vytorin

On 10 January 2023, the European Parliament’s Urban Intergroup and Micro-Mobility for Europe hosted a debate on the role of micro-mobility in the New Urban Mobility Framework (NUMF). Speakers included president MEP Jan Olbrycht (EPP, PL) and Vice-Presidents MEP Fabienne Keller (RE, FR) and MEP Andreas Schieder (S&D, AT) of the Urban Intergroup, Daniel Mes, Member of the Cabinet EVP Timmermans, Jens Müller, Policy and Research Lead, Clean Cities Campaign and Welmoed Neijmeijer from Micro-Mobility for Europe.

Panelists discussed the opportunities created by micro-mobility, as well as the challenges that the sector is confronted with. The need for more and better infrastructure for micro-mobility users, better integration with public transport, better education for road safety, the existing patchwork of applicable traffic rules, and the lack of a harmonised technical standard were raised as obstacles.

While speakers acknowledged the important role that micro-mobility already plays in diversifying the urban mobility landscape by reducing congestion and emissions, they called for action on:

• Improving infrastructure: more space and safe infrastructure encourages the safe use of micro-mobility and cycling
• Working towards harmonised technical standards: to ensure an innovation-friendly framework, EU technical requirements for personal light electric vehicles is needed for e-scooters and e-bikes
• Encourage multimodality: micro-mobility strengthens public transport via first and last-mile trips and by making the combination more attractive, car dependency can be reduced

Speaker’s statements

MEP Andreas Schieder (S&D, AT) stated that New Urban Mobility Framework comes right on time. There is a pressing need of changes in the transport in the cities, especially after the outbreak of COVID-19. He also highlighted the potential for effective use of micro-mobility, in relation to the lack of personnel (drivers) in public transport. He stated, “we can see an enormous amount of increase in the usage of e-scooters in the last year which is coming together with additional questions of infrastructure, safety and rules for parking”. MEP Schieder summarised the meeting saying that we are currently in the moment of transition and we need to know which kind of tools we can use and how we can learn from other means of transport (usage of space, safety of users, co-existence with other means of transport). At the end, he called for organising another micro-mobility meeting in the future.

MEP Jan Olbrycht (EPP, PL) identified that there is a lack of definition when it comes to micro-mobility, which should be addressed, as we need to have one understanding of what we are fighting about and only when the definition is set then EU can develop the specific regulations. Furthermore, he highlighted that “we cannot solve problems of transport without urban policy”. However, unfortunately, currently there is no clear urban policy in the European Parliament.

MEP Fabienne Keller (RE, FR) acknowledged that “sharing concepts enable citizens to try new services. We have to be careful with the rules imposed to not discourage their use” and noted that considering the weight of cars, “walking, cycling, e-scooter and e-bikes are a much preferred option”. She mentioned that there is an issue of security in Strasbourg, where the fines on micro-mobility misuses and bad practices are so high that the authorities decide not to enforce them. We need to have better rules of regulations in place. MEP Keller stated that she sees the competitions between shared and not-shared means of transport but they should complement each other. There is much need to invest in hubs and parkings for micro-mobility users and share good practises.

MEP Marcos Ros Sempere (S&D, ES) – rapporteur for opinion the New EU Urban Mobility Framework in the REGI committee admitted that there are 6 main topics in his opinion where he calls for European funding to improve multimodal, sustainable mobility focusing on public transportation and shared mobility. Moreover, he asked for only funding for mobility projects that improve the urban mobility indicators.

Daniel Mes (Cabinet EVP Timmermans) stated that “banning micro-mobility in cities is not a desirable outcome from the point of view of a member of cabinet of EVP Timmermans”. He also highlighted the contribution of young people in using micro-mobility as a sustainable form of transport. He said that “EU is also about building alliances” and that “we should respect the local part”. He also indicated that the European Commission is working on this issue.

Jens Müller, Clean Cities Campaign, referring to car dependency stated that “We urgently need to use all available options to reduce the use of polluting cars in our cities. There are plenty of workable options available to mayors to make everyone’s life better and tackle the climate crisis by letting citizens jump on shared bikes or e-scooters, while putting in place measures that guarantee road safety and a fair sharing of scarce public space”.

Welmoed Neijmeijer, Micro-Mobility for Europe, emphasised that “to maximise the societal benefits of micro-mobility solutions, infrastructure is needed and authorities must move away from car-centric spatial planning”. She also mentioned, “Brussels made good work for e-scooters and bikes”. Ms Neijmeijer called for the ending of fragmentation on the markets and getting harmonised technical rules at the European level. She agreed that we are in a transition period, that now it’s time for a new way of rearranging the cities and with that it is essential to ask right question ex. what and how people think about transportation.

Voices from the audience:

Annick Roetynck, LEVA-EU, agreed that there is no definition on micro-mobility, but there should be, because we are confronted with a range of terms, and as a result of that there is no real legislation in Europe. She also stated that we should make a clear distinction between technical regulations, and look at what already exists at the European level, and what can be improved.

Kevin Mayne, Cycling Industries Europe, mentioned that what is wanted is less impact of private cars use in the cities. There is an enormous danger in the conversations today that we micro focus on micro topics like micro-mobility. However, there is also an opportunity to say don’t dive deep into micro-mobility, dive deep into the change we really need to make and the change is the way we move. He underlines that there is a bigger picture which is more space for the sustainable modes, more space in parking, more hubs.

Pedro Homem de Gouveia, POLIS, stated that there is an issue with last mile definition and asked who is going to force the regulations. He mentioned that people are buying e-scooters en masse. For example, “in 2021, a total of 900,000 scooters were purchased in France for personal use”. In addition to technical regulations and terms of use, there is an issue of terms of operations: who controls access to the market and how companies should access that market. In the end he said that local and regional governments can’t reduce speed limits in their networks alone, they need help from other European governance bodies.

Ulrich Fikar, Association of German cities, said that lack of definition of micro-mobility raises uncertainty for German cities how to differentiate what comes on the road what comes on the pathways. He also mentioned that we do not need to get into competition between active modes and micro-mobility that is electric powered. Active modes should be still a priority for cities.

Sebestian Schlebusch, Dott, stated that there is still a big discussion on safety and because of that Micro-Mobility for Europe shared first-of-its-kind factsheet on incident data involving shared e-scooters in Europe.

Where to buy generic vytorin

The latest event of the URBAN Intergroup on 26 October was dedicated to creating a platform for the EU Institutions to discuss how our cooperation with the UN in the field of sustainable urban development can be fostered: in the spirit of the Joint Communication to the European Parliament and the Council on strengthening the EU’s contribution to rules-based multilateralism of 2021; the conclusions of the recent EU-UN High Level retreat in July 2022, and the EU Statement and commitments at the High-Level Meeting at UN General Assembly in April 2022.

The occasion for the meeting was also to celebrate UN-Habitat’s 2022 award of the Scroll of Honour – the most prestigious UN award for achievements in promoting sustainable urban development – to the URBAN Intergroup “For being effective in enabling European legislation, policies, and financing for sustainable urban development in cities and human settlements which can provide inspiration for parliaments and parliamentary assemblies in other regions of the world”.

Andreas Schieder MEP, Vice-President of URBAN Intergroup stressed that the topic of the meeting is currently aligned with what is discussed globally ex. how to implement the green deal, how to address climate and social challenges. “Cities and urban areas are the fields where improvement could be done and has to be done”.

Click on the image to watch the recording

Policy Segment:

Camila Brückner, Representative of the UN to EU, set the stage on the UN and EU alignment of strategic and operational priorities. She introduced the Urban October, she underlined the importance of Joint Communication of the European Commission and EEAS to the European Parliament and the Council on strengthening the EU’s contribution to rules-based multilateralism and its drive towards alignment with the UN, referred to UN and EU High-Level Retreat, High-Level Meeting at UN General Assembly to assess progress of the implementation of the New Urban Agenda (NUA). She emphasised that NUA is a Multi-Level Governance and territorial dimension of Agenda 2030 and accelerator of attaining SDGs.

(more…)

Where to buy generic vytorin

Multilevel Governance for the Co-production of Urban Security was the topic of the latest online event co-organised by the URBAN Intergroup and the European Forum for Urban Security (Efus) on 11 February. Jan Olbrycht, President of the Intergroup, led the discussions.

Brigitte De Deyne, International relations officer for the City of Liège, who represented Willy Demeyer Efus’ President and the Mayor of Liège, started the event with an introduction on Efus’ work – based on regular exchanges with its more than 250 member local and regional authorities from 17 EU Member States – and objectives that nourished the activities of the European Forum for Urban Security’s Security, Democracy and Cities international conference held in Nice on 20-22 October 2021. She presented Efus’ Security, Democracy and Cities Declaration, adopted during the closing session of the above-mentioned conference, which underlines the central role of cities in designing and implementing transversal security policies with mayors as one of the central figures. Moreover, signatories of the Declaration called for investing in prevention, mobilising the most adequate and agile tools and partnerships for co-production of urban security. Multilevel governance between different actors was stressed in the document with the role for the URBAN Intergroup as a key partner. Ms De Deyne called for the support of the Member of the European Parliament to implement the Declaration’s actions.

Elizabeth Johnston, Executive Director of Efus, further specified Efus’ actions and initiatives. She underlined that the definition of security constantly evolves. That is why Efus promotes a holistic approach to urban security, which involves all local actors and citizens in the co-production of policies. It considers security as a fundamental right of all people. She also expressed that both the URBAN Intergroup and Efus would share a joint interest on the topics of environment, urban transport, housing, security of senior citizens/ageing and social issues, which can be a good basis for further cooperation between the local-regional and EU level. Elizabeth Johnston also highlighted the need and utility to jointly identify tools for EU support allowing for the implementation of actions of joint interest.

Sebastian Viano, Director Europe, Euro-Mediterranean relations & External Funding at Nice Côte d’Azur metropolitan area, together with Werner Van Herle, Head of the Prevention and Security Department, City of Mechelen, presented the Partnership on Security in Public Spaces of the Urban Agenda for the EU (UAEU). This partnership was set up in 2019 as one of the 14 thematic Partnerships of the UAEU. It is co-led by Efus, the City of Nice and the City of Madrid. They explained potential benefits that would come from partnerships that can involve local and regional authorities of all sizes.. The key areas presented during the event involved the reinforcement of social cohesion, the elaboration of agile training tools for local security actors and the safety of women in public spaces.

  (more…)

Agenda of the event

European Forum for Urban Security (Efus)- background note

Efus Manifesto

Partnership on Security in Public Spaces of the Urban Agenda for the EU (UAEU)

Efus-Presentation

BeSecure-FeelSecure project-presentation

Podcast series on ensuring the security of public spaces